e-learning
resources
Stockholm 2007
Monday 17.09.2007
Anti-inflammatory therapy for childhood asthma
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Post-hoc analysis of the effect of montelukast in treating post-RSV-bronchiolitic respiratory symptoms in children
T. Reiss, B. Knorr, J. L. Marchal, M. P. Malice, H. Bisgaard (Rahway, NJ, United States Of America; Copenhagen, Denmark)
Source:
Annual Congress 2007 - Anti-inflammatory therapy for childhood asthma
Session:
Anti-inflammatory therapy for childhood asthma
Session type:
Electronic Poster Discussion
Number:
2715
Disease area:
Airway diseases, Paediatric lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
T. Reiss, B. Knorr, J. L. Marchal, M. P. Malice, H. Bisgaard (Rahway, NJ, United States Of America; Copenhagen, Denmark). Post-hoc analysis of the effect of montelukast in treating post-RSV-bronchiolitic respiratory symptoms in children. Eur Respir J 2007; 30: Suppl. 51, 2715
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Late Breaking Abstract - Efficacy of Breathox® device inhalation on acute symptoms associated with COVID-19 (BREATH study)
Related content which might interest you:
Effect of high extrafine strength (HS) ICS-containing triple therapy on exacerbations in patients with severe asthma and persistent airflow limitation: Post-hoc analysis of the TRIGGER study
Source: International Congress 2019 – Novel findings from asthma clinical trials
Year: 2019
Effect of triple therapy with extra-fine BDP/FF/GB pMDI during seasonal peaks of asthma exacerbations. A post-hoc analysis of the TRIMARAN and TRIGGER studies
Source: Virtual Congress 2020 – Inhaled corticosteroids and bronchodilator studies in asthma
Year: 2020
Inhaled antibiotics improve symptoms of cough and sputum in patients with bronchiectasis: a post-hoc analysis of the AIR-BX studies
Source: Virtual Congress 2020 – Non-tuberculous mycobacterial infections and bronchiectasis
Year: 2020
Exploratory trial on cough reflex sensitivity in patients with acute cough during URTI and post recovery.
Source: International Congress 2019 – Asthma treatment: novel insights from clinical studies
Year: 2019
Comparative analysis of prevalence and severity of bronchial asthma symptoms at 7–8-year-old and 13–14-year-old children
Source: Eur Respir J 2006; 28: Suppl. 50, 250s
Year: 2006
Clustering of respiratory symptoms in patients with a positive histamine challenge test
Source: Eur Respir J 2004; 24: Suppl. 48, 83s
Year: 2004
Effect of extrafine medium strength (MS) ICS-containing triple therapy on exacerbations in asthmatics with persistent airflow limitation: A post-hoc analysis of the TRIMARAN study
Source: International Congress 2019 – Asthma treatment: novel insights from clinical studies
Year: 2019
Safety of montelukast in children with post-RSV-bronchiolitic respiratory symptoms
Source: Annual Congress 2007 - Anti-inflammatory therapy for childhood asthma
Year: 2007
Efficacy of aclidinium/formoterol: pooled post hoc analysis of patients naïve to COPD maintenance therapy
Source: International Congress 2017 – COPD management
Year: 2017
Effect of COVID19 preventive measures on respiratory infections and symptoms in children
Source: Virtual Congress 2021 – Causes and consequences of paediatric respiratory diseases
Year: 2021
Clinical characteristics and outcomes of elderly patients with COPD: TIOSPIR® post-hoc analysis
Source: International Congress 2016 – Novel avenues in the treatment of COPD II
Year: 2016
Efficacy of multivariate analysis in differentiating between asthma and COPD in the elderly
Source: Eur Respir J 2005; 26: Suppl. 49, 275s
Year: 2005
Cost analysis for patients with severe asthma receiving omalizumab treatment
Source: International Congress 2019 – Clinical aspects of airway diseases
Year: 2019
The effect of inhaled corticosteroids on symptoms in pre-school children with asthma-like symptoms in general practice: the ASTERISK study
Source: Eur Respir J 2004; 24: Suppl. 48, 165s
Year: 2004
Does fluticasone or montelukast reduce the risk of recurency of wheezing bronchitis comparing to no intervention in children under the age of 3
Source: Annual Congress 2010 - Managing asthma and allergic disease in children
Year: 2010
LRT infections aetiology in hospitalized children and its importance for asthma exacerbation
Source: Eur Respir J 2004; 24: Suppl. 48, 639s
Year: 2004
Reducing the frequency of respiratory tract infections in severe neurological disorders by inhaled antibiotics: a retrospective data analysis
Source: ERJ Open Res, 5 (3) 00149-2018; 10.1183/23120541.00149-2018
Year: 2019
Analysis of causes and quality of patients‘ treatment with often severe asthma exacerbations
Source: Eur Respir J 2007; 30: Suppl. 51, 72s
Year: 2007
Once-daily QVA149 improves dyspnoea and health status compared with tiotropium plus formoterol in patients without ICS use: A post-hoc analysis of the QUANTIFY study
Source: International Congress 2015 – New data on established treatments for asthma and COPD
Year: 2015
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept